the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

ConditionWarts
Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age11-80
SponsorAssiut University

About this trial

To compare between the efficacy and safety of topical ivermectin alone, microneedling with topical ivermectin and topical salicylic acid in treatment of cutaneous warts.

topical ivermectin 1% will be applied on warts whole night clinical assessment will be done every 2 weeks

Microneedling will be performed on the lesion using a microneedling pen type device with a 1-cm tip diameter at a 2-mm depth setting for 2-3 minutes until pinpoint bleebing occurs 1 mL of topical ivermectin 1% will be applied on to the wart tissue.

Sessions: Sessions will be performed every 2 weeks until complete cure or for maximum 6 sessions (total 3 month)

Eligibility criteria

Qualifiers

patients with cutaneous non genital warts aged 11:80 y.

No concurrent systemic or topical treatment of warts

Disqualifiers

Genital warts.

Pregnancy and lactation.

History of any bleeding, clotting disorder or using anticoagulants

Chronic systemic diseases such as chronic renal failure, hepaticinsufficiency, and cardiovascular disorders.

Trial design

Treatments tested in this trial

  • Ivermectin
  • microneedling
  • Salicylic Acid

Treatment groups

88 Participants
are divided into 4 treatment groups

Locations

This trial has no locations

Sponsors and collaborators